Summary Expression of hCG and its free subunits by non-trophoblastic tumours is well recognised. Previously we reported hCG secretion by normal and malignant bladder epithelial cells in vitro. Here we examined culture medium from 83 different cell lines derived mainly from common epithelial tumours. Thirty-two of the cell lines were found to secrete hCG-like material into their culture media. Partial immunochemical characterisation showed that of these only choriocarcinoma and fetal tissue cell lines produced intact hCG and alpha subunit. The remaining 28 hCG-expressing epithelial cell lines, which are of mucosal origin, only secreted free beta subunit. Expression of free beta hCG by non-trophoblastic nonendocrine cells would appear to be especially characteristic of mucosal epithelia from the genitourinary and oral/respiratory tracts. Furthermore, this phenomenon may be characteristic of epithelium with transitional and/or squamous cell-like properties.Detection of human chorionic gonadotrophin (hCG) in the blood of non-pregnant subjects is most commonly associated with germ cell tumours. In addition, hCG or either of its two subunits can be found in the serum of some patients with non-gonadal epithelial tumours. The highest incidence of the latter is found with islet cell carcinomas (reviewed by Braunstein, 1983). We have previously reported the expression of the free beta subunit of hCG as a common feature of neoplastic and 'normal' bladder epithelial cells in vitro (Iles et al., 1987;. Similarly, Cowley et al. (1985) found that the secretion of free beta-hCG was a common feature of a series of head and neck squamous carcinoma cell lines. Here we report a survey of the in vitro hCG secretion by 83 cell lines, derived in the main from common epithelial tumours: lung, breast, ovarian, colorectal and bladder. The secreted hCG was further subjected to detailed immunochemical characterisation.
Materials and methodsCell culture A total of 83 established and finite cell lines were examined. These included 10 testicular germ cell tumours; three choriocarcinomas; 10 bladder cancers; eight 'normal' urothelial lines; 12 oral and genital epidermoid and squamous cell carcinoma (EC and SCC); four 'normal' oral mucosa; eight normal and transformed skin keratinocytes; five colorectal tumours; five lung carcinomas; seven breast carcinomas; and five ovarian (epithelial) tumours. Six control cell lines (three human and three murine) were also examined.